IFL (chemotherapy)
IFL (Chemotherapy)
IFL (/aɪɛfɛl/), also known as Irinotecan, Fluorouracil, and Leucovorin, is a type of chemotherapy used in the treatment of colorectal cancer.
Etymology
The term "IFL" is an acronym derived from the names of the three drugs used in this chemotherapy regimen: Irinotecan, Fluorouracil, and Leucovorin.
Pronunciation
IFL is pronounced as /aɪɛfɛl/.
Description
IFL is a combination of three drugs: Irinotecan, Fluorouracil, and Leucovorin. Irinotecan is a topoisomerase inhibitor, which works by blocking an enzyme that cancer cells need to divide and grow. Fluorouracil is an antimetabolite, which interferes with the growth of cancer cells by mimicking their building blocks and preventing them from growing. Leucovorin is used to enhance the effectiveness of fluorouracil.
Usage
IFL is primarily used in the treatment of colorectal cancer. It may also be used in the treatment of other types of cancer, as determined by a healthcare provider.
Related Terms
- Chemotherapy
- Colorectal cancer
- Irinotecan
- Fluorouracil
- Leucovorin
- Topoisomerase inhibitor
- Antimetabolite
See Also
External links
- Medical encyclopedia article on IFL (chemotherapy)
- Wikipedia's article - IFL (chemotherapy)
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski